Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Brokerages
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twelve brokerages that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, nin...